TREGZI
NDC 85866-223, allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq, kit, from Orca Biosystems Inc..
- Product NDC
- 85866-223
- Status
- Listed
- Labeler
- Orca Biosystems Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125868
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85866-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85866-223-04 | 85866022304 | 1 KIT in 1 CARTON (85866-223-04) * 100 mL in 1 BAG (85866-124-01) * 1 BAG in 1 CARTRIDGE (85866-126-02) / 15 mL in 1 BAG (85866-126-01) * 1 BAG in 1 CARTON (85866-127-02) / 30 mL in 1 BAG (85866-127-01) * 100 mL in 1 BAG (85866-125-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85866-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85866-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85866-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.